Safety of Second Generation Antipsychotics for Adult Depression

Medicine & Life Sciences

1. Antipsychotic Agents 100%
2. Depression 71%
3. Safety 54%
4. Antidepressive Agents 38%
5. Treatment-Resistant Depressive Disorder 28%
6. Dementia 17%
7. Mortality 16%
8. Delivery of Health Care 12%
9. Therapeutics 12%
10. Medicaid 11%
11. Sudden Cardiac Death 11%
12. Venous Thromboembolism 11%
13. Propensity Score 11%
14. Major Depressive Disorder 11%
15. Health Policy 10%
16. Psychological Power 10%
17. Pneumonia 8%
18. Accidental Falls 8%
19. Epidemiology 8%
20. Population 8%
21. Outpatients 7%
22. Type 2 Diabetes Mellitus 7%
23. Myocardial Infarction 7%
24. Age Groups 7%
25. Stroke 7%
26. Elderly 7%
27. Randomized Controlled Trials 7%
28. Pharmacology 7%
29. Health Care Outcome Assessment 6%
30. Demography 6%
31. Prospective Studies 6%
32. Incidence 5%